Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines

Mol Ther. 2020 Nov 4;28(11):2303-2304. doi: 10.1016/j.ymthe.2020.10.002. Epub 2020 Oct 9.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenovirus Vaccines* / adverse effects
  • Adenovirus Vaccines* / economics
  • Animals
  • Betacoronavirus
  • COVID-19
  • COVID-19 Vaccines
  • Coronavirus Infections / economics
  • Coronavirus Infections / prevention & control
  • Humans
  • Pandemics / prevention & control
  • Pneumonia, Viral / prevention & control
  • SARS-CoV-2
  • Viral Vaccines* / adverse effects
  • Viral Vaccines* / economics

Substances

  • Adenovirus Vaccines
  • COVID-19 Vaccines
  • Viral Vaccines